PHK
GMAB icon

Point72 Hong Kong’s Genmab GMAB Stock Holding History

Point72 Hong Kong’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$307K Sell
10,015
-5,362
-35% -$131K 0.01% 286
2025
Q2 		$318K Buy
+15,377
New +$316K 0.02% 282
2025
Q1 		– Sell
-43,671
Closed -$911K – 547
2024
Q4 		$911K Buy
+43,671
New +$960K 0.06% 196
2024
Q3 		– Sell
-234
Closed -$5.89K – 542
2024
Q2 		$5.89K Buy
+234
New +$6.63K ﹤0.01% 410

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's GMAB Position: Q3 2025 in Review

Point72 Hong Kong reduced its Genmab (GMAB) stake by 35% in Q3 2025, selling an estimated $131K and leaving 10,015 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #286.

Point72 Hong Kong first reported a position in GMAB in Q2 2024 and has held it in 4 quarters since. The position peaked at $911K in Q4 2024. 253 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Point72 Hong Kong held 10,015 shares of Genmab worth $307K as of Q3 2025.
  • Point72 Hong Kong sold 5,362 Genmab shares in Q3 2025, an estimated $131K.
  • Genmab made up 0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #286 holding.
  • Point72 Hong Kong first reported a position in Genmab in Q2 2024 and has held it in 4 quarters since.
  • Point72 Hong Kong's Genmab position peaked at $911K in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.